A Dark Vector Cognition product

Item 16. Form 10-K Summary

24K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

None.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AMERIPRISE FINANCIAL, INC.

Registrant

Date:February 25, 2022By/s/ Walter S. Berman
Walter S. Berman Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacity and on the dates indicated.

Date:February 25, 2022By/s/ James M. Cracchiolo
James M. Cracchiolo Chairman and Chief Executive Officer (Principal Executive Officer and Director)
Date:February 25, 2022By/s/ Walter S. Berman
Walter S. Berman Executive Vice President and Chief Financial Officer (Principal Financial Officer)
Date:February 25, 2022By/s/ John R. Hutt
John R. Hutt Senior Vice President and Controller (Principal Accounting Officer)
Date:February 25, 2022By/s/ Dianne Neal Blixt*
Dianne Neal Blixt Director
Date:February 25, 2022By/s/ Amy DiGeso*
Amy DiGeso Director
Date:February 25, 2022By/s/ Lon R. Greenberg*
Lon R. Greenberg Director
Date:February 25, 2022By/s/ Jeffrey Noddle*
Jeffrey Noddle Director
Date:February 25, 2022By/s/ Robert F. Sharpe, Jr.*
Robert F. Sharpe, Jr. Director
Date:February 25, 2022By/s/ Brian T. Shea*
Brian T. Shea Director
Date:February 25, 2022By/s/ W. Edward Walter*
W. Edward Walter Director
Date:February 25, 2022By/s/ Christopher J. Williams*
Christopher J. Williams Director
*By/s/ Walter S. Berman
Walter S. Berman Executive Vice President and Chief Financial Officer

*Walter S. Berman, by signing his name hereto on the 25th day of February, 2022 does hereby sign this document pursuant to powers of attorney duly executed by the Directors named, filed with the Securities and Exchange Commission on behalf of such Directors as Exhibit 24 to this Form 10-K, all in the capacities and on the date stated, such persons being the majority of the Directors of the Registrant.

Schedule I - Condensed Financial Information of Registrant

(Parent Company Only)

Condensed Statements of Operations - Years ended December 31, 2021, 2020 and 2019162
Condensed Balance Sheets - Years ended December 31, 2021 and 2020163
Condensed Statements of Cash Flows - Years ended December 31, 2021, 2020 and 2019164
Notes to Condensed Financial Information of Registrant165
Schedule I — Condensed Financial Information of Registrant Condensed Statements of Operations (Parent Company Only)
Years Ended December 31,
202120202019
(in millions)
Revenues
Management and financial advice fees$—$—$(1)
Net investment income27239
Other revenues91514
Gain on disposal of business——213
Total revenues3638235
Banking and deposit interest expense239
Total net revenues3435226
Expenses
Benefits, claims, losses and settlement expenses——49
Distribution expenses71224
Interest and debt expense102105126
General and administrative expense258198244
Total expenses367315443
Pretax loss before equity in earnings of subsidiaries(333)(280)(217)
Income tax provision (benefit)157(87)(38)
Loss before equity in earnings of subsidiaries(490)(193)(179)
Equity in earnings of subsidiaries, net of tax3,2501,7272,072
Net income2,7601,5341,893
Other comprehensive income (loss), net of tax(626)367553
Total comprehensive income$2,134$1,901$2,446

See Notes to Condensed Financial Information of Registrant.

Schedule I — Condensed Financial Information of Registrant Condensed Balance Sheets (Parent Company Only)
December 31,
20212020
(in millions, except share amounts)
Assets
Cash and cash equivalents$827$1,071
Investments905877
Loans to subsidiaries483247
Due from subsidiaries242497
Receivables42
Land, buildings, equipment, and software, net of accumulated depreciation of $973 and $929, respectively193208
Investments in subsidiaries7,0107,153
Other assets1,3081,334
Total assets$10,972$11,389
Liabilities and Shareholders’ Equity
Liabilities:
Accounts payable and accrued expenses$1,118$936
Due to subsidiaries8360
Borrowings from subsidiaries446494
Long-term debt2,8292,831
Other liabilities8111,201
Total liabilities5,2875,522
Shareholders’ Equity:
Common shares ($.01 par value; shares authorized, 1,250,000,000; shares issued, 334,828,117 and 332,390,132, respectively)33
Additional paid-in capital9,2208,822
Retained earnings17,52515,292
Treasury shares, at cost (223,967,107 and 215,624,519 shares, respectively)(21,066)(18,879)
Accumulated other comprehensive income (loss), net of tax, including amounts applicable to equity investments in subsidiaries3629
Total shareholders’ equity5,6855,867
Total liabilities and equity$10,972$11,389

See Notes to Condensed Financial Information of Registrant.

Schedule I — Condensed Financial Information of Registrant Condensed Statements of Cash Flows (Parent Company Only)
Years Ended December 31,
202120202019
(in millions)
Cash Flows from Operating Activities
Net income$2,760$1,534$1,893
Equity in earnings of subsidiaries(3,250)(1,727)(2,072)
Dividends received from subsidiaries4,0272,0182,721
Gain on disposal of business before affinity partner payment——(313)
Other operating activities, primarily with subsidiaries343282596
Net cash provided by (used in) operating activities3,8802,1072,825
Cash Flows from Investing Activities
Available-for-Sale securities:
Proceeds from sales—922—
Maturities, sinking fund payments and calls93161204
Purchases(82)(15)(1,153)
Proceeds from sale of other investments1—6
Purchase of other investments(16)(12)(12)
Proceeds from sale of land, buildings, equipment and software12—
Purchase of land, buildings, equipment and software(28)(54)(42)
Proceeds from disposal of business——1,138
Contributions to subsidiaries(1,291)(416)(368)
Return of capital from subsidiaries3913118
Repayment of loans from subsidiaries2,7013,2882,468
Issuance of loans to subsidiaries(2,937)(3,174)(2,457)
Acquisition of surplus loans to subsidiaries—(500)—
Other, net——(65)
Net cash provided by (used in) investing activities(1,519)333(263)
Cash Flows from Financing Activities
Dividends paid to shareholders(511)(497)(504)
Repurchase of common shares(2,030)(1,441)(1,943)
Cash paid for purchased options with deferred premiums——(107)
Issuance of long-term debt, net of issuance costs4496497
Repayments of long-term debt(9)(762)(313)
Borrowings from subsidiaries244871132
Repayments of borrowings from subsidiaries(403)(751)(79)
Exercise of stock options133
Other, net99(18)6
Net cash provided by (used in) financing activities(2,605)(2,099)(2,308)
Net increase (decrease) in cash and cash equivalents(244)341254
Cash and cash equivalents at beginning of year1,071730476
Cash and cash equivalents at end of year$827$1,071$730
Supplemental Disclosures:
Interest paid on debt$95$107$123
Income taxes paid (received), net17326(109)
Non-cash dividends from subsidiaries——81
Non-cash contributions to subsidiaries52——

See Notes to Condensed Financial Information of Registrant.

Schedule I — Condensed Financial Information of Registrant

Notes to Condensed Financial Information of Registrant (Parent Company Only)

1. Basis of Presentation

The accompanying Condensed Financial Statements include the accounts of Ameriprise Financial, Inc. (the “Parent Company”) and, on an equity basis, its subsidiaries and affiliates. The financial statements have been prepared in accordance with U.S. generally accepted accounting principles. The financial information of the Parent Company should be read in conjunction with the Consolidated Financial Statements and Notes of Ameriprise Financial, Inc. and its subsidiaries (“Ameriprise Financial”). Parent Company revenues and expenses, other than compensation and benefits and debt and interest expense, are primarily related to intercompany transactions with subsidiaries and affiliates.

The change in the fair value of derivative instruments used as hedges is reflected in the Parent Company Only Condensed Statements of Operations. For certain of these derivatives, the change in the hedged item is reflected in the subsidiaries’ Statements of Operations. The change in fair value of certain derivatives used to economically hedge risk related to guaranteed minimum withdrawal benefit (“GMWB”) provisions is included in Benefits, claims, losses and settlement expenses, while the underlying benefits, claims, losses and settlement expenses are reflected in Equity in earnings of subsidiaries.

2. Investments

On December 23, 2020, RiverSource Life Insurance Company (“RiverSource Life”) issued a $500 million unsecured 3.5% surplus note due December 31, 2050 to the Parent Company. The surplus note is subordinate in right of payment to the prior payment in full of the RiverSource Life’s obligations to policyholders, claimants and beneficiaries and all other creditors. No payment of principal or interest shall be made without the prior approval of the Minnesota Department of Commerce and such payments shall be made only from RiverSource Life’s statutory surplus. Interest payments are due semi-annually in arrears on June 30 and December 31, which commenced on June 30, 2021. Subject to the preceding conditions, RiverSource Life may prepay all or a portion of the principal at any time. The held-to-maturity investment of $500 million as of both December 31, 2021 and 2020 is recorded in Investments on the Parent Company’s Condensed Balance Sheets. For the year ended December 31, 2021, interest income was $17 million and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.

In December 2018, the Parent Company invested in the residual tranche of an asset backed security structure issued by Ameriprise Advisor Financing, LLC, a subsidiary of the Parent Company. The asset backed securities are collateralized by a portfolio of loans issued to advisors affiliated with Ameriprise Financial Services, LLC (“AFS”), a subsidiary of the Parent Company. The fair value of the residual tranche was $100 million and $90 million as of December 31, 2021 and 2020, respectively, and is reported in Investments on the Parent Company’s Condensed Balance Sheets. For the years ended December 31, 2021, 2020 and 2019, interest income was $7 million, $6 million and $6 million, respectively, and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.

3. Debt

All of the debt of Ameriprise Financial is borrowings of the Parent Company, except as indicated below.

  • As of both December 31, 2021 and 2020, Ameriprise Financial had $200 million of borrowings from the Federal Home Loan Bank of Des Moines, which is collateralized with commercial mortgage backed securities and residential mortgage backed securities.

  • As of December 31, 2021, Ameriprise Financial debt included $3 million of other subsidiary lease obligations.

4. Borrowings from Subsidiaries

The Parent Company has intercompany lending arrangements with its subsidiaries. At the end of each business day, taking into consideration all legal and regulatory requirements associated with its subsidiaries, the Parent Company is entitled to draw on all funds in specified bank accounts. Repayment of all or a portion of the funds is due on demand. As of December 31, 2021 and 2020, the Company had $431 million and $334 million, respectively, available for repayment due on demand. The Parent Company also has revolving credit agreements with its subsidiaries as the borrower aggregating $1.4 billion and $1.3 billion as of December 31, 2021 and 2020, respectively, of which $15 million and $172 million was outstanding as of December 31, 2021 and 2020, respectively.

5. Guarantees, Commitments and Contingencies

The Parent Company is the guarantor for operating leases of certain subsidiaries. All consolidated legal, regulatory and arbitration proceedings, including class actions of Ameriprise Financial, Inc. and its consolidated subsidiaries are potential or current obligations of the Parent Company. The Parent Company has committed revolving credit agreements with its subsidiaries as the lender aggregating $366 million as of both December 31, 2021 and 2020, respectively, of which $243 million and nil was outstanding as of December 31, 2021 and 2020, respectively.

The Parent Company and Ameriprise Certificate Company (“ACC”) entered into a Capital Support Agreement on March 2, 2009, pursuant to which the Parent Company agrees to commit such capital to ACC as is necessary to satisfy applicable minimum capital requirements. Effective April 30, 2014, this agreement was amended to revise the maximum commitment to $50 million. For the years ended December 31, 2021, 2020 and 2019, ACC did not draw upon the Capital Support Agreement and had met all applicable capital requirements.

AFS entered into a Financial Industry Regulatory Authority approved subordinated loan agreement with the Parent Company on December 15, 2014 for regulatory net capital purposes. The agreement consists of a $200 million secured demand note. The note is secured

by cash and securities equal to the principal value of the note pledged by the Parent Company. As of December 31, 2021, AFS had not made a demand of the principal amount.

Ameriprise Enterprise Investment Services, Inc. (“AEIS”) entered into a FINRA approved subordinated loan agreement with the Parent Company on January 25, 2017 for regulatory net capital purposes. Under this agreement, AEIS borrowed $60 million from the Parent Company with an initial term of five years to be repaid no later than January 22, 2022. Both companies have the option to renew the agreement in one year-increments in perpetuity. In January 2022, the agreement was renewed for one year extending the maturity date to January 22, 2023.

6. Subsequent Event

On February 23, 2022, RiverSource Life’s Board of Directors declared a cash dividend of $300 million to the Parent Company, payable on or after March 25, 2022, pending approval by the Minnesota Department of Commerce.

Previous: Item 15. Exhibits and Financial Statement Schedules